Altimmune(ALT) - 2022 Q1 - Earnings Call Transcript

Altimmune, Inc. (NASDAQ:ALT) Q1 2022 Earnings Conference Call May 12, 2022 8:30 AM ET Company Participants Vipin K. Garg – President and Chief Executive Officer Richard Eisenstadt – Chief Financial Officer Scot Roberts – Chief Scientific Officer Scott M. Harris – Chief Medical Officer Conference Call Participants Seamus Fernandez – Guggenheim Partners Yasmeen Rahimi – Piper Sandler Companies Liisa Bayko – Evercore ISI Mayank Mamtani – B. Riley Securities Jonathan Wolleben – JMP Securities LLC Operator [Oper ...